BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Droguerre M, Duchêne A, Picoli C, Portal B, Lejards C, Guiard BP, Meunier J, Villard V, Déglon N, Hamon M, Mouthon F, Charvériat M. Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer's Disease. Front Neurosci 2020;14:563. [PMID: 32612499 DOI: 10.3389/fnins.2020.00563] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Vidal B, Pereira M, Valdebenito M, Vidal L, Mouthon F, Zimmer L, Charvériat M, Droguerre M. Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model. J Psychopharmacol 2022;:2698811221128963. [PMID: 36205074 DOI: 10.1177/02698811221128963] [Reference Citation Analysis]
2 Hugon G, Goutal S, Sarazin M, Bottlaender M, Caillé F, Droguerre M, Charvériat M, Winkeler A, Tournier N. Impact of Donepezil on Brain Glucose Metabolism Assessed Using [18F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide. Front Neurosci 2022;16:835577. [PMID: 35281502 DOI: 10.3389/fnins.2022.835577] [Reference Citation Analysis]
3 Bigarreau J, Rouach N, Perrier AL, Mouthon F, Charvériat M. Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models. Int J Mol Sci 2022;23:1684. [PMID: 35163606 DOI: 10.3390/ijms23031684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 da Costa A, Picoli C, Mouthon F, Charvériat M. Automated Assays to Identify Modulators of Transcription Factor EB Translocation and Autophagy. Assay Drug Dev Technol 2021. [PMID: 34898267 DOI: 10.1089/adt.2021.119] [Reference Citation Analysis]
5 Charvériat M, Darmoni SJ, Lafon V, Moore N, Bordet R, Veys J, Mouthon F; SFPT Translational Research in Pharmacology group. Use of real-world evidence in translational pharmacology research. Fundam Clin Pharmacol 2021. [PMID: 34676579 DOI: 10.1111/fcp.12734] [Reference Citation Analysis]
6 Le Douce J, Delétage N, Bourdès V, Lemarchant S, Godfrin Y. Subcommissural Organ-Spondin-Derived Peptide Restores Memory in a Mouse Model of Alzheimer's Disease. Front Neurosci 2021;15:651094. [PMID: 34194293 DOI: 10.3389/fnins.2021.651094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Charvériat M, Lafon V, Mouthon F, Zimmer L. Innovative approaches in CNS drug discovery. Therapies 2021;76:101-9. [DOI: 10.1016/j.therap.2020.12.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Charvériat M, Mouthon F, Rein W, Verkhratsky A. Connexins as therapeutic targets in neurological and neuropsychiatric disorders. Biochim Biophys Acta Mol Basis Dis 2021;1867:166098. [PMID: 33545299 DOI: 10.1016/j.bbadis.2021.166098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Deguil J, Bordet R. Contributions of animal models of cognitive disorders to neuropsychopharmacology. Therapie 2021;76:87-99. [PMID: 33589315 DOI: 10.1016/j.therap.2021.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Charvériat M, Guiard BP. Serotonergic neurons in the treatment of mood disorders: The dialogue with astrocytes. Prog Brain Res 2021;259:197-228. [PMID: 33541677 DOI: 10.1016/bs.pbr.2021.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lopez S, Del Percio C, Forloni G, Frasca A, Drinkenburg WH, Lizio R, Noce G, Ferri R, Soricelli A, Stocchi F, Vacca L, Bordet R, Richardson JC, Babiloni C. Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG Study. Int J Mol Sci 2020;21:E9072. [PMID: 33260655 DOI: 10.3390/ijms21239072] [Reference Citation Analysis]
12 Vidal B, Droguerre M, Valdebenito M, Zimmer L, Hamon M, Mouthon F, Charvériat M. Pharmaco-fUS for Characterizing Drugs for Alzheimer's Disease - The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine. Front Neurosci 2020;14:835. [PMID: 32903470 DOI: 10.3389/fnins.2020.00835] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]